Cardiovascular Disease Clinical Trial
Official title:
Comparison of Screening Tools for Coronary Artery Disease With Thallium Scintigraphy in Adult Population in Karachi.
Coronary artery disease (CAD) is a silent killer that may go undetected for years. It is the leading cause of death with no limitation to geographic boundaries accounting to about 16.7 million deaths world wide. Different studies have shown that South Asians populations are more prone to CAD where it is emerging as an epidemic. According to a study conducted in Karachi it is estimated that the overall prevalence of cardiovascular diseases in Pakistan is 26.9% with 23.7% in men and 30.0% in women. However tools for measuring CAD have not being adequately validated. This study is designed to develop screening tools and to determine test characteristics of Rose Questionnaire and Minnesota Coded ECG alone and in combination for diagnosis of CAD, using MPI as gold standard in Pakistan.
Design: The proposed study is a cross sectional study of a population sample of 450 subjects
aged > 40 years, and stratified by gender, residing in 12 randomly selected communities in
Karachi, Pakistan.
The target population for this study would be drawn from an existing population based study
entitled “Population based strategies for effective control of high blood pressure in
Pakistan” (parent study), conducted by the primary supervisor and study director (TJ) in
Karachi Subjects aged > 40 years would be eligible. Detailed information on each participant
would be obtained from data collected for the parent study. This includes a)
socio-demographic characteristics such as level of education, occupation, economic status,
ethnicity, tobacco use , physical activity defined on the basis of International Physical
Activity Questionnaire, dietary habits (food frequency questionnaire), family history of
CAD, and the WHO standard Rose questionnaire (RQ) for coronary artery disease (CAD) (b)
anthropometry including height, weight, waist and hip circumference (c) laboratory tests
including fasting blood glucose, lipid profile, serum creatinine, and urine albumin to
creatinine ratio. The community health workers (CHW) would administer RQ and obtain 12-lead
EKG. They would give an appointment to subjects for MPI at the Aga Khan University Hospital.
Each individual will then go through an exercise treadmill test (symptom limited Bruce or
modified Bruce protocols) if able to walk, or pharmacological stress by the infusion of
dobutamine or dipyridamole if unable to walk. The results of MPI study would be delivered to
the subjects with interpretation by cardiologists, and referral to a physician (as
appropriate).
Classification of Screening instruments: ECG will be Minnesota coded by two trained and
independent coders, and discrepant reports will be resolved with a third independent coder.
All cases of probable or possible CAD on Minnesota coding of ECG would be classified as “MC
ECG positive for CAD” RQ will be coded according to standardized criteria into “positives
for "angina" and "history of possible infarction" . Presence of either one would be
classified as “RQ positive for CAD”.
;
Allocation: Random Sample, Primary Purpose: Screening, Time Perspective: Cross-Sectional
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|